Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

ARMEN KHACHATRYAN

Allopathic & Osteopathic Physicians Orthopaedic Surgery

NPI
1114930781
CMS profile
5275
Location
WEST JORDAN, UT

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2023 · Entire year

$168,422.98

152 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2023 · entire year · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $142,303.23 47
Travel and Lodging $22,468.92 54
Food and Beverage $3,650.83 51

By paying entity

PY2023 · entire year · sorted by reported total

Paying entityAmountRecords
ZIMVIE INC. $61,200.22 74
Orthofix Medical, Inc. $55,841.44 27
Medacta USA, Inc. $30,434.41 12
Dymicron $9,562.50 1
Centinel Spine, LLC $8,269.40 8
NuVasive, Inc. $2,719.93 13
Medtronic, Inc. $145.10 10
DePuy Synthes Sales Inc. $85.95 1
PAINTEQ LLC $74.41 1
Spineart USA Inc $24.09 1
ABBVIE INC. $18.34 1
Abbott Laboratories $16.90 1
Stryker Corporation $15.28 1
Boston Scientific Corporation $15.01 1

Page 3 of 4; records 101–150 of 152 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

ARMEN KHACHATRYAN

NPI 1114930781 · CMS profile ID 5275

Allopathic & Osteopathic Physicians / Orthopaedic Surgery

WEST JORDAN, UT

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 3 of 4; records 101–150 of 152 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1114930781?year=2023&recipient=provider&page=3#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
ARMEN KHACHATRYAN, NPI 1114930781, CMS profile ID 5275. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 4; records 101–150 of 152 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1114930781?year=2023&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
APA 7
IndustryPayments. (2026). ARMEN KHACHATRYAN, NPI 1114930781, CMS profile ID 5275. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 4; records 101–150 of 152 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1114930781?year=2023&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
Bluebook
ARMEN KHACHATRYAN, NPI 1114930781, CMS profile ID 5275, IndustryPayments, General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 3 of 4; records 101–150 of 152 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9. https://industrypayments.org/provider/npi-1114930781?year=2023&recipient=provider&page=3#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2023 · Physicians and non-physician practitioners · CMS publication 2026-06-30

152 matching records · $168,422.98 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 152 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 101–150 of 152.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
ZIMVIE INC. $178.9002/24/2023 Travel and Lodging No dispute reported Delay: No
Change: CHANGED
06/30/2026 1052304993 CMS
ZIMVIE INC. $739.3602/24/2023 Travel and Lodging No dispute reported Delay: No
Change: CHANGED
06/30/2026 1052305001 CMS
ZIMVIE INC. $114.0002/24/2023 Travel and Lodging No dispute reported Delay: No
Change: CHANGED
06/30/2026 1052305015 CMS
ZIMVIE INC. $57.0002/24/2023 Travel and Lodging No dispute reported Delay: No
Change: CHANGED
06/30/2026 1052305023 CMS
ZIMVIE INC. $126.0002/24/2023 Travel and Lodging No dispute reported Delay: No
Change: CHANGED
06/30/2026 1052305029 CMS
ZIMVIE INC. $27.7302/24/2023 Food and Beverage No dispute reported Delay: No
Change: CHANGED
06/30/2026 1052305037 CMS
ZIMVIE INC. $34.0002/24/2023 Travel and Lodging No dispute reported Delay: No
Change: CHANGED
06/30/2026 1052305625 CMS
ZIMVIE INC. $18.0002/24/2023 Travel and Lodging No dispute reported Delay: No
Change: CHANGED
06/30/2026 1052305631 CMS
ZIMVIE INC. $14.0002/24/2023 Travel and Lodging No dispute reported Delay: No
Change: CHANGED
06/30/2026 1052305637 CMS
Medacta USA, Inc. $154.1502/23/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1043383879 CMS
Medtronic, Inc. $13.1502/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1019078119 CMS
ZIMVIE INC. $18.3702/22/2023 Food and Beverage No dispute reported Delay: No
Change: CHANGED
06/30/2026 1052304975 CMS
ZIMVIE INC. $35.0002/22/2023 Travel and Lodging No dispute reported Delay: No
Change: CHANGED
06/30/2026 1052304981 CMS
ZIMVIE INC. $1,800.0002/22/2023 Consulting Fee No dispute reported Delay: No
Change: CHANGED
06/30/2026 1052305575 CMS
ZIMVIE INC. $900.0002/22/2023 Consulting Fee No dispute reported Delay: No
Change: CHANGED
06/30/2026 1052305581 CMS
ZIMVIE INC. $1,800.0002/22/2023 Consulting Fee No dispute reported Delay: No
Change: CHANGED
06/30/2026 1052305587 CMS
ZIMVIE INC. $2,250.0002/22/2023 Consulting Fee No dispute reported Delay: No
Change: CHANGED
06/30/2026 1052305593 CMS
ZIMVIE INC. $1,800.0002/22/2023 Consulting Fee No dispute reported Delay: No
Change: CHANGED
06/30/2026 1052305599 CMS
ZIMVIE INC. $2,025.0002/22/2023 Consulting Fee No dispute reported Delay: No
Change: CHANGED
06/30/2026 1052305605 CMS
ZIMVIE INC. $1,575.0002/22/2023 Consulting Fee No dispute reported Delay: No
Change: CHANGED
06/30/2026 1052305613 CMS
ZIMVIE INC. $900.0002/22/2023 Consulting Fee No dispute reported Delay: No
Change: CHANGED
06/30/2026 1052305619 CMS
Medtronic, Inc. $9.2402/09/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1019078109 CMS
ABBVIE INC. $18.3402/08/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997631603 CMS
Orthofix Medical, Inc. $117.1302/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1017385199 CMS
ZIMVIE INC. $74.6802/02/2023 Food and Beverage No dispute reported Delay: No
Change: CHANGED
06/30/2026 1052304969 CMS
Medacta USA, Inc. $14,200.0001/26/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1043383873 CMS
Stryker Corporation $15.2801/26/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1006751735 CMS
Centinel Spine, LLC $150.5701/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1044403523 CMS
Medtronic, Inc. $4.2401/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1019078093 CMS
Medtronic, Inc. $17.9101/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1019078101 CMS
Orthofix Medical, Inc. $33.3401/20/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1017384925 CMS
Orthofix Medical, Inc. $37.6001/20/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1017384929 CMS
Orthofix Medical, Inc. $51.6101/20/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1017384935 CMS
Orthofix Medical, Inc. $42.9601/20/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1017384939 CMS
Orthofix Medical, Inc. $315.8101/20/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1017384943 CMS
Orthofix Medical, Inc. $12,110.0001/20/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1017384951 CMS
Orthofix Medical, Inc. $8,650.0001/20/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1017384955 CMS
Orthofix Medical, Inc. $10.5501/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1017385161 CMS
Orthofix Medical, Inc. $113.4901/20/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1017385211 CMS
ZIMVIE INC. $284.4001/20/2023 Travel and Lodging No dispute reported Delay: No
Change: CHANGED
06/30/2026 1052304947 CMS
ZIMVIE INC. $90.9401/20/2023 Food and Beverage No dispute reported Delay: No
Change: CHANGED
06/30/2026 1052304987 CMS
ZIMVIE INC. $80.2801/20/2023 Food and Beverage No dispute reported Delay: No
Change: CHANGED
06/30/2026 1052305009 CMS
ZIMVIE INC. $333.9601/19/2023 Travel and Lodging No dispute reported Delay: No
Change: CHANGED
06/30/2026 1052304933 CMS
ZIMVIE INC. $356.0101/19/2023 Travel and Lodging No dispute reported Delay: No
Change: CHANGED
06/30/2026 1052304957 CMS
ZIMVIE INC. $254.5601/19/2023 Travel and Lodging No dispute reported Delay: No
Change: CHANGED
06/30/2026 1052304963 CMS
ZIMVIE INC. $34.0001/19/2023 Travel and Lodging No dispute reported Delay: No
Change: CHANGED
06/30/2026 1052305569 CMS
Centinel Spine, LLC $150.0001/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1044403531 CMS
Centinel Spine, LLC $345.6901/18/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1044403539 CMS
PAINTEQ LLC $74.4101/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 991391501 CMS
ZIMVIE INC. $900.0001/04/2023 Consulting Fee No dispute reported Delay: No
Change: CHANGED
06/30/2026 1052305693 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $133,086.97 110
PY2020 $156,920.27 102
PY2021 $163,905.00 129
PY2022 $243,829.68 144
PY2023 $168,422.98 152
PY2024 $87,947.09 115
PY2025 $52,122.04 61

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $140,964.25 53
PY2024 Principal investigator $257,492.25 52
PY2023 Principal investigator $1,053,866.75 77
PY2022 Principal investigator $792,798.50 87
PY2021 Recipient $305,907.50 1
PY2021 Principal investigator $527,727.00 67
PY2020 Principal investigator $83,759.00 23
PY2019 Principal investigator $3,167.00 2

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

53 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Globus Medical, Inc. $2,359.00 12/30/2025 Non-covered Recipient Entity
SPARTA SPINE LLC
Long-Term Assessment of the Safety and Performance of the NuVasive Simplify Disc at Two Levels No dispute reported 06/30/2026 1236866232
Principal investigator 1 Centinel Spine, LLC $790.00 12/26/2025 Non-covered Recipient Entity
Sparta Spine LLC
A Multicenter, Prospective, Randomized, Controlled Trial Comparing the Safety and Effectiveness of Prodisc C SK and Prodisc C Vivo to Mobi-C Cervical Disc in the Treatment of Two-Level Symptomatic Cervical Disc Disease (SCDD) No dispute reported 06/30/2026 1238856457
Principal investigator 1 Spineart SA $16,013.75 12/23/2025 Non-covered Recipient Entity
Sparta Spine LLC
BAGUERA-C IDE No dispute reported 06/30/2026 1242122145
Principal investigator 1 Centinel Spine, LLC $790.00 11/26/2025 Non-covered Recipient Entity
Sparta Spine LLC
A Multicenter, Prospective, Randomized, Controlled Trial Comparing the Safety and Effectiveness of Prodisc C SK and Prodisc C Vivo to Mobi-C Cervical Disc in the Treatment of Two-Level Symptomatic Cervical Disc Disease (SCDD) No dispute reported 06/30/2026 1238856445
Principal investigator 1 Centinel Spine, LLC $790.00 11/26/2025 Non-covered Recipient Entity
Sparta Spine LLC
A Multicenter, Prospective, Randomized, Controlled Trial Comparing the Safety and Effectiveness of Prodisc C SK and Prodisc C Vivo to Mobi-C Cervical Disc in the Treatment of Two-Level Symptomatic Cervical Disc Disease (SCDD) No dispute reported 06/30/2026 1238856447
Principal investigator 1 Centinel Spine, LLC $419.00 11/26/2025 Non-covered Recipient Entity
Sparta Spine LLC
A Multicenter, Prospective, Randomized, Controlled Trial Comparing the Safety and Effectiveness of Prodisc C SK and Prodisc C Vivo to Mobi-C Cervical Disc in the Treatment of Two-Level Symptomatic Cervical Disc Disease (SCDD) No dispute reported 06/30/2026 1238856449
Principal investigator 1 Centinel Spine, LLC $419.00 11/26/2025 Non-covered Recipient Entity
Sparta Spine LLC
A Multicenter, Prospective, Randomized, Controlled Trial Comparing the Safety and Effectiveness of Prodisc C SK and Prodisc C Vivo to Mobi-C Cervical Disc in the Treatment of Two-Level Symptomatic Cervical Disc Disease (SCDD) No dispute reported 06/30/2026 1238856451
Principal investigator 1 Centinel Spine, LLC $790.00 11/26/2025 Non-covered Recipient Entity
Sparta Spine LLC
A Multicenter, Prospective, Randomized, Controlled Trial Comparing the Safety and Effectiveness of Prodisc C SK and Prodisc C Vivo to Mobi-C Cervical Disc in the Treatment of Two-Level Symptomatic Cervical Disc Disease (SCDD) No dispute reported 06/30/2026 1238856453
Principal investigator 1 Centinel Spine, LLC $790.00 11/26/2025 Non-covered Recipient Entity
Sparta Spine LLC
A Multicenter, Prospective, Randomized, Controlled Trial Comparing the Safety and Effectiveness of Prodisc C SK and Prodisc C Vivo to Mobi-C Cervical Disc in the Treatment of Two-Level Symptomatic Cervical Disc Disease (SCDD) No dispute reported 06/30/2026 1238856455
Principal investigator 1 Globus Medical, Inc. $1,567.00 11/04/2025 Non-covered Recipient Entity
SPARTA SPINE LLC
Long-Term Assessment of the Safety and Performance of the NuVasive Simplify Disc at Two Levels No dispute reported 06/30/2026 1236865725
Principal investigator 1 Spineart SA $4,772.50 10/30/2025 Non-covered Recipient Entity
Sparta Spine LLC
BAGUERA-C IDE No dispute reported 06/30/2026 1242122143
Principal investigator 1 Centinel Spine, LLC $790.00 10/23/2025 Non-covered Recipient Entity
Sparta Spine LLC
A Multicenter, Prospective, Randomized, Controlled Trial Comparing the Safety and Effectiveness of Prodisc C SK and Prodisc C Vivo to Mobi-C Cervical Disc in the Treatment of Two-Level Symptomatic Cervical Disc Disease (SCDD) No dispute reported 06/30/2026 1238856443
Principal investigator 1 Spineart SA $11,241.25 09/19/2025 Non-covered Recipient Entity
Sparta Spine LLC
BAGUERA-C IDE No dispute reported 06/30/2026 1242122141
Principal investigator 1 Centinel Spine, LLC $790.00 09/04/2025 Non-covered Recipient Entity
Sparta Spine LLC
A Multicenter, Prospective, Randomized, Controlled Trial Comparing the Safety and Effectiveness of Prodisc C SK and Prodisc C Vivo to Mobi-C Cervical Disc in the Treatment of Two-Level Symptomatic Cervical Disc Disease (SCDD) No dispute reported 06/30/2026 1238856437
Principal investigator 1 Centinel Spine, LLC $790.00 09/04/2025 Non-covered Recipient Entity
Sparta Spine LLC
A Multicenter, Prospective, Randomized, Controlled Trial Comparing the Safety and Effectiveness of Prodisc C SK and Prodisc C Vivo to Mobi-C Cervical Disc in the Treatment of Two-Level Symptomatic Cervical Disc Disease (SCDD) No dispute reported 06/30/2026 1238856439
Principal investigator 1 Centinel Spine, LLC $790.00 09/04/2025 Non-covered Recipient Entity
Sparta Spine LLC
A Multicenter, Prospective, Randomized, Controlled Trial Comparing the Safety and Effectiveness of Prodisc C SK and Prodisc C Vivo to Mobi-C Cervical Disc in the Treatment of Two-Level Symptomatic Cervical Disc Disease (SCDD) No dispute reported 06/30/2026 1238856441
Principal investigator 1 Spineart SA $9,056.25 08/26/2025 Non-covered Recipient Entity
Sparta Spine LLC
BAGUERA-C IDE No dispute reported 06/30/2026 1242122139
Principal investigator 1 Centinel Spine, LLC $790.00 08/12/2025 Non-covered Recipient Entity
Sparta Spine LLC
A Multicenter, Prospective, Randomized, Controlled Trial Comparing the Safety and Effectiveness of Prodisc C SK and Prodisc C Vivo to Mobi-C Cervical Disc in the Treatment of Two-Level Symptomatic Cervical Disc Disease (SCDD) No dispute reported 06/30/2026 1238856433
Principal investigator 1 Centinel Spine, LLC $790.00 08/12/2025 Non-covered Recipient Entity
Sparta Spine LLC
A Multicenter, Prospective, Randomized, Controlled Trial Comparing the Safety and Effectiveness of Prodisc C SK and Prodisc C Vivo to Mobi-C Cervical Disc in the Treatment of Two-Level Symptomatic Cervical Disc Disease (SCDD) No dispute reported 06/30/2026 1238856435
Principal investigator 1 Centinel Spine, LLC $790.00 07/09/2025 Non-covered Recipient Entity
Sparta Spine LLC
A Multicenter, Prospective, Randomized, Controlled Trial Comparing the Safety and Effectiveness of Prodisc C SK and Prodisc C Vivo to Mobi-C Cervical Disc in the Treatment of Two-Level Symptomatic Cervical Disc Disease (SCDD) No dispute reported 06/30/2026 1238856415
Principal investigator 1 Centinel Spine, LLC $790.00 07/09/2025 Non-covered Recipient Entity
Sparta Spine LLC
A Multicenter, Prospective, Randomized, Controlled Trial Comparing the Safety and Effectiveness of Prodisc C SK and Prodisc C Vivo to Mobi-C Cervical Disc in the Treatment of Two-Level Symptomatic Cervical Disc Disease (SCDD) No dispute reported 06/30/2026 1238856417
Principal investigator 1 Centinel Spine, LLC $790.00 07/09/2025 Non-covered Recipient Entity
Sparta Spine LLC
A Multicenter, Prospective, Randomized, Controlled Trial Comparing the Safety and Effectiveness of Prodisc C SK and Prodisc C Vivo to Mobi-C Cervical Disc in the Treatment of Two-Level Symptomatic Cervical Disc Disease (SCDD) No dispute reported 06/30/2026 1238856419
Principal investigator 1 Centinel Spine, LLC $790.00 07/09/2025 Non-covered Recipient Entity
Sparta Spine LLC
A Multicenter, Prospective, Randomized, Controlled Trial Comparing the Safety and Effectiveness of Prodisc C SK and Prodisc C Vivo to Mobi-C Cervical Disc in the Treatment of Two-Level Symptomatic Cervical Disc Disease (SCDD) No dispute reported 06/30/2026 1238856421
Principal investigator 1 Centinel Spine, LLC $790.00 07/09/2025 Non-covered Recipient Entity
Sparta Spine LLC
A Multicenter, Prospective, Randomized, Controlled Trial Comparing the Safety and Effectiveness of Prodisc C SK and Prodisc C Vivo to Mobi-C Cervical Disc in the Treatment of Two-Level Symptomatic Cervical Disc Disease (SCDD) No dispute reported 06/30/2026 1238856423
Principal investigator 1 Centinel Spine, LLC $790.00 07/09/2025 Non-covered Recipient Entity
Sparta Spine LLC
A Multicenter, Prospective, Randomized, Controlled Trial Comparing the Safety and Effectiveness of Prodisc C SK and Prodisc C Vivo to Mobi-C Cervical Disc in the Treatment of Two-Level Symptomatic Cervical Disc Disease (SCDD) No dispute reported 06/30/2026 1238856425
Principal investigator 1 Centinel Spine, LLC $419.00 07/09/2025 Non-covered Recipient Entity
Sparta Spine LLC
A Multicenter, Prospective, Randomized, Controlled Trial Comparing the Safety and Effectiveness of Prodisc C SK and Prodisc C Vivo to Mobi-C Cervical Disc in the Treatment of Two-Level Symptomatic Cervical Disc Disease (SCDD) No dispute reported 06/30/2026 1238856427
Principal investigator 1 Centinel Spine, LLC $790.00 07/09/2025 Non-covered Recipient Entity
Sparta Spine LLC
A Multicenter, Prospective, Randomized, Controlled Trial Comparing the Safety and Effectiveness of Prodisc C SK and Prodisc C Vivo to Mobi-C Cervical Disc in the Treatment of Two-Level Symptomatic Cervical Disc Disease (SCDD) No dispute reported 06/30/2026 1238856429
Principal investigator 1 Centinel Spine, LLC $1,035.00 07/09/2025 Non-covered Recipient Entity
Sparta Spine LLC
A Multicenter, Prospective, Randomized, Controlled Trial Comparing the Safety and Effectiveness of Prodisc C SK and Prodisc C Vivo to Mobi-C Cervical Disc in the Treatment of Two-Level Symptomatic Cervical Disc Disease (SCDD) No dispute reported 06/30/2026 1238856431
Principal investigator 1 Spineart SA $37,518.75 07/07/2025 Non-covered Recipient Entity
Sparta Spine LLC
BAGUERA-C IDE No dispute reported 06/30/2026 1242122137
Principal investigator 1 Centinel Spine, LLC $790.00 05/21/2025 Non-covered Recipient Entity
Sparta Spine LLC
A Multicenter, Prospective, Randomized, Controlled Trial Comparing the Safety and Effectiveness of Prodisc C SK and Prodisc C Vivo to Mobi-C Cervical Disc in the Treatment of Two-Level Symptomatic Cervical Disc Disease (SCDD) No dispute reported 06/30/2026 1238856413
Principal investigator 1 Centinel Spine, LLC $790.00 04/30/2025 Non-covered Recipient Entity
Sparta Spine LLC
A Multicenter, Prospective, Randomized, Controlled Trial Comparing the Safety and Effectiveness of Prodisc C SK and Prodisc C Vivo to Mobi-C Cervical Disc in the Treatment of Two-Level Symptomatic Cervical Disc Disease (SCDD) No dispute reported 06/30/2026 1238856403
Principal investigator 1 Centinel Spine, LLC $790.00 04/30/2025 Non-covered Recipient Entity
Sparta Spine LLC
A Multicenter, Prospective, Randomized, Controlled Trial Comparing the Safety and Effectiveness of Prodisc C SK and Prodisc C Vivo to Mobi-C Cervical Disc in the Treatment of Two-Level Symptomatic Cervical Disc Disease (SCDD) No dispute reported 06/30/2026 1238856405
Principal investigator 1 Centinel Spine, LLC $790.00 04/30/2025 Non-covered Recipient Entity
Sparta Spine LLC
A Multicenter, Prospective, Randomized, Controlled Trial Comparing the Safety and Effectiveness of Prodisc C SK and Prodisc C Vivo to Mobi-C Cervical Disc in the Treatment of Two-Level Symptomatic Cervical Disc Disease (SCDD) No dispute reported 06/30/2026 1238856407
Principal investigator 1 Centinel Spine, LLC $790.00 04/30/2025 Non-covered Recipient Entity
Sparta Spine LLC
A Multicenter, Prospective, Randomized, Controlled Trial Comparing the Safety and Effectiveness of Prodisc C SK and Prodisc C Vivo to Mobi-C Cervical Disc in the Treatment of Two-Level Symptomatic Cervical Disc Disease (SCDD) No dispute reported 06/30/2026 1238856409
Principal investigator 1 Centinel Spine, LLC $790.00 04/30/2025 Non-covered Recipient Entity
Sparta Spine LLC
A Multicenter, Prospective, Randomized, Controlled Trial Comparing the Safety and Effectiveness of Prodisc C SK and Prodisc C Vivo to Mobi-C Cervical Disc in the Treatment of Two-Level Symptomatic Cervical Disc Disease (SCDD) No dispute reported 06/30/2026 1238856411
Principal investigator 1 Spineart SA $15,122.50 04/11/2025 Non-covered Recipient Entity
Sparta Spine LLC
BAGUERA-C IDE No dispute reported 06/30/2026 1242122135
Principal investigator 1 Globus Medical, Inc. $3,053.00 04/03/2025 Non-covered Recipient Entity
SPARTA SPINE LLC
Long-Term Assessment of the Safety and Performance of the NuVasive Simplify Disc at Two Levels No dispute reported 06/30/2026 1236865727
Principal investigator 1 Centinel Spine, LLC $790.00 04/02/2025 Non-covered Recipient Entity
Sparta Spine LLC
A Multicenter, Prospective, Randomized, Controlled Trial Comparing the Safety and Effectiveness of Prodisc C SK and Prodisc C Vivo to Mobi-C Cervical Disc in the Treatment of Two-Level Symptomatic Cervical Disc Disease (SCDD) No dispute reported 06/30/2026 1238856397
Principal investigator 1 Centinel Spine, LLC $790.00 04/02/2025 Non-covered Recipient Entity
Sparta Spine LLC
A Multicenter, Prospective, Randomized, Controlled Trial Comparing the Safety and Effectiveness of Prodisc C SK and Prodisc C Vivo to Mobi-C Cervical Disc in the Treatment of Two-Level Symptomatic Cervical Disc Disease (SCDD) No dispute reported 06/30/2026 1238856399
Principal investigator 1 Centinel Spine, LLC $790.00 04/02/2025 Non-covered Recipient Entity
Sparta Spine LLC
A Multicenter, Prospective, Randomized, Controlled Trial Comparing the Safety and Effectiveness of Prodisc C SK and Prodisc C Vivo to Mobi-C Cervical Disc in the Treatment of Two-Level Symptomatic Cervical Disc Disease (SCDD) No dispute reported 06/30/2026 1238856401
Principal investigator 1 Globus Medical, Inc. $427.00 03/13/2025 Non-covered Recipient Entity
SPARTA SPINE LLC
Long-Term Assessment of the Safety and Performance of the NuVasive Simplify Disc at Two Levels No dispute reported 06/30/2026 1236865389
Principal investigator 1 Globus Medical, Inc. $169.00 03/13/2025 Non-covered Recipient Entity
SPARTA SPINE LLC
Long-Term Assessment of the Safety and Performance of the NuVasive Simplify Disc at Two Levels No dispute reported 06/30/2026 1236865561
Principal investigator 1 Globus Medical, Inc. $792.00 03/13/2025 Non-covered Recipient Entity
SPARTA SPINE LLC
Long-Term Assessment of the Safety and Performance of the NuVasive Simplify Disc at Two Levels No dispute reported 06/30/2026 1236866404
Principal investigator 1 Spineart SA $7,762.50 02/26/2025 Non-covered Recipient Entity
Sparta Spine LLC
BAGUERA-C IDE No dispute reported 06/30/2026 1242122133
Principal investigator 1 Centinel Spine, LLC $790.00 02/12/2025 Non-covered Recipient Entity
Sparta Spine LLC
A Multicenter, Prospective, Randomized, Controlled Trial Comparing the Safety and Effectiveness of Prodisc C SK and Prodisc C Vivo to Mobi-C Cervical Disc in the Treatment of Two-Level Symptomatic Cervical Disc Disease (SCDD) No dispute reported 06/30/2026 1238856391
Principal investigator 1 Centinel Spine, LLC $419.00 02/12/2025 Non-covered Recipient Entity
Sparta Spine LLC
A Multicenter, Prospective, Randomized, Controlled Trial Comparing the Safety and Effectiveness of Prodisc C SK and Prodisc C Vivo to Mobi-C Cervical Disc in the Treatment of Two-Level Symptomatic Cervical Disc Disease (SCDD) No dispute reported 06/30/2026 1238856393
Principal investigator 1 Centinel Spine, LLC $1,035.00 02/12/2025 Non-covered Recipient Entity
Sparta Spine LLC
A Multicenter, Prospective, Randomized, Controlled Trial Comparing the Safety and Effectiveness of Prodisc C SK and Prodisc C Vivo to Mobi-C Cervical Disc in the Treatment of Two-Level Symptomatic Cervical Disc Disease (SCDD) No dispute reported 06/30/2026 1238856395
Principal investigator 1 Centinel Spine, LLC $790.00 02/05/2025 Non-covered Recipient Entity
Sparta Spine LLC
A Multicenter, Prospective, Randomized, Controlled Trial Comparing the Safety and Effectiveness of Prodisc C SK and Prodisc C Vivo to Mobi-C Cervical Disc in the Treatment of Two-Level Symptomatic Cervical Disc Disease (SCDD) No dispute reported 06/30/2026 1238856381
Principal investigator 1 Centinel Spine, LLC $790.00 02/05/2025 Non-covered Recipient Entity
Sparta Spine LLC
A Multicenter, Prospective, Randomized, Controlled Trial Comparing the Safety and Effectiveness of Prodisc C SK and Prodisc C Vivo to Mobi-C Cervical Disc in the Treatment of Two-Level Symptomatic Cervical Disc Disease (SCDD) No dispute reported 06/30/2026 1238856383
Principal investigator 1 Centinel Spine, LLC $790.00 02/05/2025 Non-covered Recipient Entity
Sparta Spine LLC
A Multicenter, Prospective, Randomized, Controlled Trial Comparing the Safety and Effectiveness of Prodisc C SK and Prodisc C Vivo to Mobi-C Cervical Disc in the Treatment of Two-Level Symptomatic Cervical Disc Disease (SCDD) No dispute reported 06/30/2026 1238856385
Principal investigator 1 Centinel Spine, LLC $790.00 02/05/2025 Non-covered Recipient Entity
Sparta Spine LLC
A Multicenter, Prospective, Randomized, Controlled Trial Comparing the Safety and Effectiveness of Prodisc C SK and Prodisc C Vivo to Mobi-C Cervical Disc in the Treatment of Two-Level Symptomatic Cervical Disc Disease (SCDD) No dispute reported 06/30/2026 1238856387
Principal investigator 1 Centinel Spine, LLC $790.00 02/05/2025 Non-covered Recipient Entity
Sparta Spine LLC
A Multicenter, Prospective, Randomized, Controlled Trial Comparing the Safety and Effectiveness of Prodisc C SK and Prodisc C Vivo to Mobi-C Cervical Disc in the Treatment of Two-Level Symptomatic Cervical Disc Disease (SCDD) No dispute reported 06/30/2026 1238856389
Principal investigator 1 Spineart SA $1,293.75 01/06/2025 Non-covered Recipient Entity
Sparta Spine LLC
BAGUERA-C IDE No dispute reported 06/30/2026 1242122131

Ownership and Investment Interests

One row per program year and measure, newest year first · the amount invested and the value of the interest are never added together

Program yearMeasureAmountRecords
PY2025 Amount invested $0.00 1
PY2025 Value of interest $32,000.00 1

Ownership and Investment Interests are a separate CMS dataset, shown here separately and never added to payments.

Ownership and investment interests are reported as the value of an interest held, not as a payment received. They are a different measure from the payment total on this page and are never combined with it.

Ownership and Investment Interests records

Ordering applied by this site (program year, newest first, then company) · record values are shown as CMS published them

1 record · PY2025

Ownership and Investment Interests records (CSV)

Program yearCompanyAmount invested Value of interestTerms of interestInterest held by Dispute statusPublishedRecord ID
PY2025 Overture Orthopaedics $0.00 $32,000.00 Preferred stock ownership. Physician Covered Recipient No dispute reported 06/30/2026 1254108578